Arcutis Biotherapeutics, Inc.
NasdaqGS:ARQT
$ 9.20
+ $0.08 (0.88%)
$ 9.20
+ $0.08 (0.88%)
End-of-day quote: 05/17/2024

ARQT: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
NYSE:ABBV
AbbVie
166.42 -23.06% -12.89% 293,875.72 3.77% 7.03%
NasdaqGS:AMGN
Amgen
312.47 -12.26% -3.47% 167,619.75 2.86% 5.31%
NYSE:PFE
Pfizer
28.64 8.42% 38.65% 162,291.22 5.81% -9.31%
NYSE:BMY
Bristol-Myers Squibb
44.03 61.74% 72.08% 89,253.22 5.44% 13.54%
NSEI:SUNPHARMA
Sun Pharmaceutical Industries
1531.40 -18.2% -6.48% 3,674,341.57 0.81% 24.54%
TSE:4502
Takeda Pharmaceutical Company
4130.00 0% 0% 6,479,696.8 4.74% 0%
TSE:4523
Eisai
6779.00 0% 0% 1,968,631.52 2.33% 0%
NasdaqGM:VRCA
Verrica Pharmaceuticals
8.67 0% 0% 405.54 0% 0%
ASX:MYX
Mayne Pharma Group
6.37 -,102.84% -,101.6% 565.6 0% 0%
ASX:BOT
Botanix Pharmaceuticals
0.19 0% 0% 222.78 0% 0%
NasdaqCM:VYNE
VYNE Therapeutics
2.77 0% 0% 38.07 0% 0%
NasdaqGM:SLGL
Sol-Gel Technologies
0.75 0% 0% 26.19 0% -,564.29%
OTCPK:NOVN.Q
NVN Liquidation
0.00 0% 0% 0 0% 0%